Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-12 Sale | 2024-08-14 4:24 pm | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 16,041 | $4.7363 | $75,975 | 236,771 (Direct) | View |
| 2024-03-12 Sale(A) | 2024-04-17 4:12 pm | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 11,537 | $3.164 | $36,503 | 252,812 (Direct) | View |
| 2024-03-11 Sale | 2024-03-12 8:04 pm | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 29,768 | $3.3125 | $98,605 | 649,156 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-09 Option Award | 2024-03-12 8:04 pm | N/A 2034-03-08 | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 405,450 | $0 | 649,156 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 4:27 pm | N/A 2033-02-27 | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 220,258 | $0 | 220,258 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 4:34 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 255,078 | $0 | 342,947 (Direct) | View |
| 2022-03-30 Option Award | 2022-04-01 7:37 pm | N/A 2032-03-29 | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 314,395 | $0 | 337,869 (Direct) | View |
| 2021-04-12 Option Award | 2021-04-14 7:24 pm | N/A 2031-04-11 | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 116,201 | $0 | 116,201 (Direct) | View |
Ownership | 2020-12-18 6:06 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer | 0 | $0 | 325,635 (Direct) | View |